Keros Therapeutics (KROS) Shares Outstanding (2019 - 2025)
Historic Shares Outstanding for Keros Therapeutics (KROS) over the last 7 years, with Q3 2025 value amounting to $40.6 million.
- Keros Therapeutics' Shares Outstanding rose 349.91% to $40.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.6 million, marking a year-over-year increase of 349.91%. This contributed to the annual value of $40.6 million for FY2024, which is 2736.6% up from last year.
- As of Q3 2025, Keros Therapeutics' Shares Outstanding stood at $40.6 million, which was up 349.91% from $40.6 million recorded in Q2 2025.
- Keros Therapeutics' 5-year Shares Outstanding high stood at $40.6 million for Q3 2025, and its period low was $23.3 million during Q1 2021.
- Its 5-year average for Shares Outstanding is $31.1 million, with a median of $29.7 million in 2023.
- Its Shares Outstanding has fluctuated over the past 5 years, first soared by 83397.18% in 2021, then skyrocketed by 314.38% in 2022.
- Over the past 5 years, Keros Therapeutics' Shares Outstanding (Quarter) stood at $24.0 million in 2021, then increased by 14.88% to $27.5 million in 2022, then rose by 15.6% to $31.8 million in 2023, then increased by 27.37% to $40.6 million in 2024, then increased by 0.19% to $40.6 million in 2025.
- Its last three reported values are $40.6 million in Q3 2025, $40.6 million for Q2 2025, and $40.6 million during Q1 2025.